COMMUNIQUÉS West-GlobeNewswire

Cytori to Present New Strategic Direction
13/06/2019
Company to Announce New Therapeutic Area Focus and Brand Identity Plans SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) “the Company” will provide a live webcast to discuss its [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2019
13/06/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
North American Partners in Anesthesia (NAPA) expands from cardiac care to full-service anesthesia delivery at St. Mary’s General Hospital
13/06/2019
NAPA’s expansion in northern New Jersey opens opportunities for anesthesia clinicians dedicated to safety, quality, and creating exceptional patient experiences. MELVILLE, N.Y., June 13, 2019 (GLOBE NEWSWIRE) -- North [...]
Novan to Participate in JMP Securities Life Sciences Conference
13/06/2019
MORRISVILLE, N.C., June 13, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it will participate in the 2019 JMP Securities Life Sciences Conference in New York on [...]
Kymab Announces Presentations at the 24th EHA Annual Congress
13/06/2019
Kymab Announces Presentations at the 24 th EHA Annual Congress Two Company-sponsored oral and poster abstracts to be presented on KY1049 and IntelliSelect ® Bispecifics platform Cambridge, UK; June 13, 2019 : Kymab, a [...]
Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults
13/06/2019
NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
TCAR Achieves Favorable Outcomes vs. Carotid Endarterectomy in Patients with Carotid Artery Disease
13/06/2019
Updated Results of TCAR Surveillance Project Presented at Society for Vascular Surgery Vascular Annual Meeting NATIONAL HARBOR, Md., June 13, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company [...]
CV Sciences, Inc. to Present at the Oppenheimer 19th Annual Consumer Conference
13/06/2019
LAS VEGAS, June 13, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating [...]
iCAD lance la solution ProFound AI™ 2D pour la mammographie en Europe
13/06/2019
Au Congrès de la SIFEM, la société présente sa nouvelle plateforme logicielle d’intelligence artificielle, ProFound AI 2D pour la mammographie ainsi que sa solution pour la tomosynthèse (DBT) 3D NASHUA, N.H. et LILLE, [...]
Driven Deliveries Inc. Announces Partnership with Pure Ratios
13/06/2019
Driven continues to add revenue producing brands to its cannabis delivery platform SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the world’s first and only publicly traded cannabis [...]
Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy for the Treatment of Metastatic Prostate Cancer
13/06/2019
NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]
Arbutus to Participate at JMP Securities Life Sciences Conference
13/06/2019
WARMINSTER, Pa., June 13, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia and Dr. [...]
Homology Medicines to Present at JMP Securities Life Sciences Conference
13/06/2019
BEDFORD, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will present at the JMP Securities Life Sciences Conference [...]
Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update
13/06/2019
TORONTO, June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Easton Pharmaceuticals Inc. (OTC: EAPH ) (“Easton” or “the Company”) announces it has filed its quarterly report for the three months ended March 31, 2019, [...]
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
13/06/2019
WOODLAND HILLS, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ [...]
Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)
13/06/2019
Provides funding for additional preclinical experiments and for the MYODA preparations for the clinical study in Duchenne muscular dystrophy (DMD) PARIS and CAMBRIDGE, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- Biophytis [...]
Organovo to Present at Raymond James Life Sciences and MedTech Conference
13/06/2019
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]
Immutep Completes Recruitment of Initial Cohort in 1st Line NSCLC Patients for TACTI-002 Trial
13/06/2019
Recruitment for 2 nd line (PD-1 refractory) NSCLC and 2 nd line HNSCC cohorts of the TACTI-002 trial, conducted in collaboration with MSD, are ongoing Initial data from the TACTI-002 study expected mid-2019 SYDNEY, [...]
Bellerophon to Present at the JMP Securities Life Sciences Conference
13/06/2019
WARREN, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief [...]

Pages